1d
Zacks Investment Research on MSNIs it the Right Time to Hold Alcon Stock in Your Portfolio Now?Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...
22h
The Healthy @Reader's Digest on MSNHere’s How Long To Wait Between Cataract Surgery on Each Eye, Say 2 Expert Eye DoctorsTerry Kim, MD, is a board-certified ophthalmologist, Chief Medical Officer at Alcon, and Professor of Ophthalmology at Duke ...
A TikTok video has become a cautionary tale – one of many that often go viral in hopes of warning people about a dangerous ...
Ocular surface discomfort can be problematic after cataract surgery. Italian researchers tested the use of cyclosporine A 0.1 ...
Doctors with a Colorado hospital system are urging eye drop users to read labels carefully after noting an uptick in cases of people accidentally putting glue into their eyes.
Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Alcon is debuting Systane PRO Preservative-Free (PF) as the latest over-the-counter eye drop in the company’s dry eye portfolio. Systane PRO PF is the longest lasting eye drop in the Systane ...
Continuous Glucose Monitor Data Predicts Type 1 Diabetes Complications Jan. 15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes ...
Ointments have the advantage of increased dwell time in the eye, but often patients and parents of children prefer drops, and no therapeutic advantage of one over the other has been demonstrated.
The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results